Topical Doxorubicin Hydrochloride Therapy for Carcinoma in Situ of the Bladder: A Followup
- 1 January 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 131 (1) , 41-42
- https://doi.org/10.1016/s0022-5347(17)50186-x
Abstract
Patients (10) with histologically proved carcinoma in situ of the bladder had remission of tumor after topical chemotherapy with doxorubicin hydrochloride for 24 mo. Of the 10 patients 3 suffered new areas of carcinoma in situ 9-12 mo. after termination of intravesical chemotherapy. Of these 3 patients (1) had a distal ureteral tumor. Fibrosis of the submucosal tissue was observed in every patient but a decrease in bladder capacity was observed in only 1 with prior radiotherapy.This publication has 6 references indexed in Scilit:
- TRIAL OF THE THERAPEUTIC EFFICACY OF CIS-DIAMINO-DICHLORO-PLATINUM BY LOCAL INSTILLATIONS ON BLADDER-TUMORS RECURRING AT THE ORIGINAL SITE1982
- The Effect of Mitomycin C on Superficial Bladder CancerJournal of Urology, 1981
- Intracavitary Doxorubicin Hydrochloride Therapy for Carcinoma in Situ of the BladderJournal of Urology, 1981
- „NORMAL” urothelium in patients with bladder cancer.A preliminary report from the national bladder cancer collaborative group aCancer, 1979
- Serial Multiple-Site Biopsies in Patients with Bladder CancerJournal of Urology, 1978
- Non-Invasive Papillary Carcinoma of the Bladder Associated with Carcinoma in SituJournal of Urology, 1976